Although serum IGF-II was higher in IS cases both in the acute phase and after 3 months compared to controls (p < 0.05 and p < 0.01, respectively), there was no significant post-stroke difference between the acute and 3-month s-IGF-II levels. This evidence concerns the gene IGF2 and Stroke.